Overview

OTO-104 for Meniere's Disease

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety of OTO-104 in subjects with unilateral Meniere's disease. The effectiveness of OTO-104 to reduce the symptoms of Meniere's disease will also be evaluated.

Phase:

Phase 1

Details

Lead Sponsor:

Otonomy, Inc.